NEOCARDIUM

NeoCardium Limited is a company incorporated in United Kingdom with a focus in developing and assisting development of a new category of cardiology devices. The clinical indications for company's proprietary device technology include applications in the practice of interventional cardiology and the new branch of Regenerative Cardiology... Since the device is a Class IIa under European Classification of devices the cost and time to market for this indication will be significantly low. There are other clinical indications that Company's technology platform can be deployed. The Company is currently soliciting investors / partners for developing Company's flagship indication for preventing post-angioplasty in-stent restenosis

Also known as: NeoCardium Limited

Primary location: Sussex United Kingdom